Pharmaceutical Contract Manufacturing and Research Services Companies, Corporate Growth and Market Forecast

Pharmaceutical Contract Manufacturing and Research Services Market Top Vendors and Their Offerings

Company Profile

Market Value Chain Analysis

R&D

• The R&D of the pharmaceutical contract manufacturing and research services focuses on the development of specialized drug delivery systems, scaling complex manufacturing processes, and AI-driven data analytics for clinical trial acceleration.
• Key players: Lonza Group, Thermo Fisher Scientific, WuXi AppTec.

Clinical Trials and Regulatory Approvals

• Patient safety protocol, adherence to the good clinical practices (GCP) standards, and integrity of data submitted are evaluated in the clinical trials and regulatory approvals of the pharmaceutical contract manufacturing and research services.
• Key players: Thermo Fisher Scientific, IQVIA, ICON.

Packaging and Serialization

• The packaging and serialization of the pharmaceutical contract manufacturing and research services involve the use of specialized packaging and high-tech serialization services with integration of unique 2D barcodes and track-and-trace systems.
• Key players: Thermo Fisher Scientific, Recipharm, Catalent.

Patient Support and Services

• Patient recruitment and retention programs, decentralized clinical trials platforms, and specialized “hub” services are provided in the patient support and services of the pharmaceutical contract manufacturing and research services.
• Key players: IQVIA, Parexel, ICON.

Market Growth

The global pharmaceutical contract manufacturing and research services market size was estimated at USD 281.68 billion in 2025 and is predicted to increase from USD 301.23 billion in 2026 to approximately USD 551.01 billion by 2035, expanding at a CAGR of 6.94% from 2026 to 2035.

What are the Recent Developments in the Market?

• In February 2026, an e-marketing portal, a one-stop digital marketplace of the Bulk Drug Manufacturers Association of India (BDMAI), was launched, which will support the Indian contract research and manufacturing services (CRAM)/contract development and manufacturing organization (CDMO) services, APIs, impurities, intermediates, pellets, and intermediates in domestic and global markets.
• In January 2026, a biopharmaceutical contract manufacturing agreement was signed between Rakuten Medical, Inc. and LOTTE Biologics to support the development of Alluminox®â€¯platform-based photoimmunotherapy, an oncology therapy of Rakuten Medical, Inc., where advanced manufacturing services for monoclonal antibody intermediates and their conjugates will be provided by LOTTE Biologics.

Now it’s easier than ever to manage all your market services data in one place - Access the Dashboard.